{"url":"https://lda.senate.gov/api/v1/filings/578d1083-4ac8-45ac-90bf-b92b2f736f66/","filing_uuid":"578d1083-4ac8-45ac-90bf-b92b2f736f66","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2021,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/578d1083-4ac8-45ac-90bf-b92b2f736f66/print/","filing_document_content_type":"text/html","income":null,"expenses":"1310000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Katie Oppenheim","dt_posted":"2021-10-20T16:29:43.893000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1455 PENNSYLVANIA AVENUE NW","registrant_address_2":"SUITE 500","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":56838,"url":"https://lda.senate.gov/api/v1/registrants/56838/","house_registrant_id":35186,"name":"SANOFI US SERVICES INC.","description":"sanofi-aventis U.S. Inc. discovers, develops, and markets prescription pharmaceuticals","address_1":"1455 PENNSYLVANIA AVENUE NW","address_2":"SUITE 500","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATIE OPPENHEIM","contact_telephone":"+1 202-585-3000","dt_updated":"2026-07-30T19:07:40.607412-04:00"},"client":{"id":159929,"url":"https://lda.senate.gov/api/v1/clients/159929/","client_id":12,"name":"SANOFI US SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-12-11"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Issues related to TRIPS Waiver.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54496,"prefix":"mrs","prefix_display":"MRS.","first_name":"AMY","nickname":null,"middle_name":"L","last_name":"REDL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOR","general_issue_code_display":"Torts","description":"Issues related to S.2428 \"False Claims Act\".","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to importation; issues related to WTO Trips Waiver; and general trade issues.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to S.1435 \"Affordable Prescriptions for Patients Act of 2021\".","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to tax reform; general issues related to taxes; issues related to Orphan Drug Tax Credit; issues related to H.R. 3656 \"Vaccine Access Improvement Act of 2021\"; issues related to 163(n) interest limitation; and issues related to Base Erosion and Anti-Abuse (BEAT) tax.","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54496,"prefix":"mrs","prefix_display":"MRS.","first_name":"AMY","nickname":null,"middle_name":"L","last_name":"REDL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to HR 3 \"Lower Drug Costs Now Act of 2019\"; issues related to drug pricing; issues related to Drug Pricing in H.R.5376 \"Build Back Better Act\"; issues related to influenza vaccines; issues related to RSV Access; issues related to routine immunization rates; general issues related to vaccines; issues related to 340B; issues related to insulin pricing; issues related to funding for Pandemic influenza; issues related to Bipartisan Infrastructure Package; issues related to HR 550 \"Immunization Infrastructure Modernization Act\"; issues related to HR 3655 \"Vaccine Injury Compensation Modernization Act\"; issues related to RX to OTC switch; issues related to S.1132 \"EPI Act\"; issues related to HR 19 \"Lower Costs, More Cures Act of 2021\"; issues related Counterfeits in S.936 \"INFORM Consumers Act\"; issues related to Counterfeits in S.1843 \"SHOP SAFE Act\"; issues related to Pandemic Preparedness; issues related to Cures 2.0; issues related to Platform Technologies; issues related to Medicare Sequestration; issues related to Reconciliation; and issues related to Intellectual Property.","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":54496,"prefix":"mrs","prefix_display":"MRS.","first_name":"AMY","nickname":null,"middle_name":"L","last_name":"REDL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":84813,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"BRADLEY-JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to S.912 \"Protecting Seniors through Immunization Act; issues related to H.R. 2170 \"HAPI Act\"; and issues related to H.R. 1978 \"Protecting Seniors through Immunization Act\".","foreign_entity_issues":"Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.","lobbyists":[{"lobbyist":{"id":139849,"prefix":"ms","prefix_display":"MS.","first_name":"CLAIRE","nickname":null,"middle_name":"WILLIS","last_name":"BRANDEWIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67581,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"OPPENHEIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54496,"prefix":"mrs","prefix_display":"MRS.","first_name":"AMY","nickname":null,"middle_name":"L","last_name":"REDL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}